Mechanism & Pharmacology of Oxymetholone
Oxymetholone is a synthetic 17α-alkylated anabolic-androgenic steroid derived from dihydrotestosterone (DHT), distinguished by its exceptionally high anabolic rating of approximately 320 relative to testosterone. Despite its structural origin from DHT, oxymetholone does not bind the androgen receptor with high affinity in the classical sense; instead, the compound exerts a significant portion of its anabolic activity through non-AR-mediated pathways, including potent stimulation of erythropoietin (EPO) synthesis in renal peritubular cells. This action drives red blood cell proliferation and raises haematocrit values markedly — clinical studies in anaemia patients recorded haemoglobin increases of 3–5 g/dL over 12-week treatment courses — which translates directly into expanded oxygen-carrying capacity and substantially improved muscular endurance under load.
At the molecular level, oxymetholone binds the androgen receptor with moderate affinity yet still upregulates nitrogen retention and protein anabolic signalling within skeletal muscle. The compound also interacts with the progesterone receptor to a limited degree, which contributes to some of its side-effect profile. Oral bioavailability is high — estimated above 90% — attributable to the 17α-methyl group that protects the molecule from first-pass hepatic metabolism. This same modification, however, places a measurable burden on hepatic enzymes (ALT, AST), making cycle duration an important consideration for experienced users.
Plasma half-life ranges from 8 to 9 hours, which supports once- or twice-daily dosing protocols that maintain relatively stable serum concentrations. The compound is not aromatised directly into oestrogen via the aromatase enzyme pathway, yet oestrogenic effects such as water retention are well-documented — a paradox attributed in part to oxymetholone's direct activation of oestrogen receptors. This makes AI co-administration a common strategic choice among users despite the technical non-aromatisation. Peak plasma concentration is typically reached within 1–2 hours of oral ingestion, and the compound clears detection windows faster than many injectables, though metabolites remain traceable in urine for up to 8 weeks via high-resolution mass spectrometry.
Application Context & User Groups
Within the bodybuilding context, oxymetholone occupies a specific and well-understood role: it is a rapid-acting bulking agent capable of producing dramatic increases in scale weight and muscular fullness within the first two to four weeks of use. Reports from structured off-season programmes consistently describe gains of 6–10 kg over a 4–6 week cycle, though a substantial proportion of this represents intramuscular glycogen supercompensation and fluid retention rather than contractile tissue alone.
The primary user group for oxymetholone consists of experienced anabolic steroid users who have already completed multiple cycles with milder androgens and are seeking to accelerate a mass phase. Because of its potency and hepatotoxicity profile, oxymetholone is rarely recommended — even within informed circles — as a first compound. It is most commonly positioned as a cycle-kickstart, front-loading a bulking stack during the first 4–6 weeks while longer-estered injectable base compounds such as testosterone enanthate or nandrolone decanoate build to effective serum levels.
Powerlifters and strength athletes represent another distinct user group. The compound's ability to rapidly increase intracellular water content and ATP regeneration capacity correlates with notable short-term strength surges — bench press and squat totals of 20–40 kg over 3–4 weeks have been anecdotally reported in strength sport communities. Some advanced athletes also use low-dose oxymetholone mid-cycle to support connective tissue hydration, exploiting the water-retaining properties to cushion joints under extreme loading, though this is an off-label and individual application.
Clinical use of oxymetholone has a legitimate historical basis: it was approved by the US FDA for the treatment of anaemia caused by deficient red blood cell production, as well as for conditions such as osteoporosis and muscle-wasting diseases, including HIV-associated weight loss. Approved doses in those settings ranged from 1–5 mg/kg/day. For context, this information underscores the compound's genuine pharmacological potency and should not be interpreted as dosing guidance. Individuals considering oxymetholone should be fully informed of applicable legal frameworks in their jurisdiction.
Range & Selection by Concentration and Pack Size
The oxymetholone category on this platform spans three concentration tiers — 10 mg, 25 mg, and 50 mg per tablet — across pack sizes ranging from 20 to 100 tablets, giving users precise control over daily intake and cycle economics.
10 mg tablets represent the lowest available concentration and suit users who require very fine-grained dose titration. This tier is less commonly stocked in the broader market, making its availability here notable for those managing tolerability carefully during an introductory phase with the compound.
25 mg tablets occupy a middle tier with practical versatility. OxyTrex 25mg/tab 100 Tablets by Concentrex Labs is the primary representative at this concentration, offering a 100-tablet pack that delivers significant cycle volume. At 25 mg per unit, users can achieve daily intakes of 50–75 mg through straightforward two- or three-tablet protocols without the need to split tablets, which is particularly relevant for maintaining dosing consistency.
50 mg tablets are the most widely available concentration and the format most closely associated with the compound's reputation in performance contexts. Several products sit in this tier:
- Anapolon 50mg/tab 20 Tablets by Abdi Ibrahim — one of the most historically recognised pharmaceutical-grade presentations, with the compact 20-tablet pack suited to short, defined kickstart protocols.
- Anapolon 50mg/tab 60 Tablets by Balkan Pharmaceuticals — a 60-tablet format offering flexibility for either a standard 4-week run at higher daily doses or a more conservative 6-week approach.
- Pro-Anadrol 50mg/tab 50 Tablets by Beligas Pharmaceuticals — a 50-tablet pack from a well-known modern manufacturer, positioned toward users who value production transparency.
- Oxymetholon 50mg/tab 100 Tablets by Dragon-Pharma — the highest-volume option in this tier, delivering 100 tablets at 50 mg, which accommodates extended cycles or users planning to keep a reserve supply.
- Anadrolus 50mg/tab 50 Tablets by Driada Medical — another quality 50-tablet offering, rounding out the selection for those with manufacturer preferences within European production.
Across all tiers, 25 manufacturers are represented in this category, ensuring that users can compare production sources, excipient profiles, and packaging formats. Those new to the compound are advised to consider lower-pack options initially, while experienced users may find the larger 100-tablet packs more economically structured for planned mass phases.
Frequently Asked Questions
What is the difference between 25 mg and 50 mg oxymetholone tablets?
The difference is purely the amount of active ingredient per tablet, affecting how precisely you can structure daily intake without splitting tablets. At 25 mg, doses of 50 mg or 75 mg per day require two or three tablets. At 50 mg, the same doses use one or one-and-a-half tablets. The pharmacological action of oxymetholone is identical regardless of tablet strength; concentration choice is a matter of dosing convenience and availability from your preferred manufacturer.
Why does oxymetholone cause water retention if it doesn't aromatise into oestrogen?
Despite not converting via aromatase into oestrogen, oxymetholone appears to directly activate oestrogen receptors in target tissues, triggering fluid retention through mechanisms independent of the aromatase enzyme. Additionally, its effects on aldosterone-related pathways may contribute to sodium and water retention at the renal level. This is why users often co-administer selective oestrogen receptor modulators or other compounds to manage this effect, even though technically no aromatisation is occurring.
How many products are available in the oxymetholone category and which pack sizes are stocked?
This category lists 25 products from 25 different manufacturers. Pack sizes available include 20, 30, 50, 60, and 100 tablets, with concentrations of 10 mg, 25 mg, and 50 mg per tablet. This range allows users to select based on cycle length, preferred daily dose, and manufacturer. Notable brands include Abdi Ibrahim, Balkan Pharmaceuticals, Beligas Pharmaceuticals, Dragon-Pharma, Concentrex Labs, and Driada Medical, among others.
Lab Tested
